Effect of thyroid hormone on plasma apolipoproteins and ApoA- and ApoB-containing lipoprotein particles

European Journal of Clinical Investigation

Volumn 28, Issue 4, 1998, Pages 266-270

  Liu, X Q ^a   Rahman, A ^b   Bagdade, J D ^a,d   Alaupovic, P ^c   Kannan, C R ^b  

^a RUSH MEDICAL COLLEGE   (United States)

^b Jr Hospital of Cook County   (United States)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d PeaceHealth Oregon   (United States)

Author keywords

Hypothyroidism; Lipoprotein particles; LPA I, LPB

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LEVOTHYROXINE SODIUM; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; SUBSTITUTION THERAPY;

APOLIPOPROTEINS A; APOLIPOPROTEINS B; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; FEMALE; HUMANS; MALE; MIDDLE AGED; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE; TRIGLYCERIDES;

EID: 0031968629     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00274.x     Document Type: Article

References (22)

1. Alaupovic P. Conceptual development of the classification systems of plasma lipoproteins. Protides Biol Fluids Proc Colloq 1972; 19: 9-19.
2. Alaupovic P. The significance of apolipoproteins for structure, function and classification of plasma lipoproteins. In: Bradley W.A. Gianturco S.H. and Segrest J.P. eds. Methods in Enzymology. Plasma Lipoproteins, Parc C, Quantitation. San Diego: Acadaemic Press, 1996: 32-60.
3. Musliner TA, Krauss RM. Lipoprotein subspecies and risk of coronary disease. Clin Chem 1988; 34: B78-83.
4. Alaupovic P, Hodis HN, Knight-Gibson C et al. Effects of lovastatin on apoA- and apoB-containing lipoproteins families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS). Arterioscler Thromb 1994; 14: 1906-14.
5. Cheung M, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but not A-II. J Biol Chem 1984; 259: 12201-9.
6. Muls E, Rosseneu M, Blaton V, Lesaffre E, Lamberigts G, De Moor P. Serum lipid and apolipoproteins A-I, A-II and B in primary hypothyroidism before and during treatment. Eur J Clin Invest 1984; 14: 12-5.
7. Pazos F, Alvarez JJ, Rubiesprat J, Varela C, Lasuncion MA. Long term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins. J Clin Endocrinol Metab 1995; 80: 562-66.
8. Kuusi T, Taskinen MR, Nikkila EA. Lipoptoteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. J Clin Endocrinol Metab 1988; 66: 51-6.
9. Abrams JJ, Grundy SM, Ginsberg H. Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res 1981; 22: 323-38.
10. Packard CJ, Shepherd J, Lindsay GM, Gaw A, Taskinen MR. Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism. J Clin Endocrinol Metab 1993; 76: 1209-16.
11. Bligh EC, Dyer WJ. A rapid method of total lipid extraction and purification. J Biochem Physiol 1959; 37: 911-7.
12. Bekaet ED, Alaupovic P, Knight-Gibson C, Blackett P, Ayrault-Jarrier M. Composition of plasma apoA-containing lipoprotein particles in children and adults. Pediatr Res 1991; 29: 315-21.
13. Alaupovic P, Lee DM, McConathy WJ. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta 1972; 260: 689-707.
14. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates. Clin Chem 1990; 36: 1431-5.
15. Alaupovic P, Bard JM, Tavella M, Shafer D. Identification of apoB-containing lipoprotein families in NIDDM. Diabetes 1992; 41: 18-25.
16. Lippel K, Tyroler HS, Gotto JrA et al. Workshop on apolipoprotein quantification. Arteriosclerosis 1983; 3: 452-64.
17. Salter AM, Hayashi R, Al Seeni M. Effects of hypothyroidism and high-fat feeding on mRNA concentrations for the low density lipoprotein receptor and on acyl-COA:cholesterol acyltransferase activities in rat liver. Biochem J 1991; 276: 825-32.
18. Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJ, Myant NB. Defects of receptor-mediated low density lipoprotein catabolisms in homozygous familial hypercholesterolemia and hypothyroidism in vivo. Proc Natl Acad Sci USA 1981; 78: 2591-5.
19. Kuusi T, Sacrinen P, Nikkila EA. Evidence of the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein 2 in men. Atherosclerosis 1980; 36: 589-93.
20. Valemarsson S, Hedner P, Nilsson-Ehle P. Reversal of decreased hepatic lipase and lipoprotein lipase activities after treatment of hypothyroidism. Eur J Clin Invest 1982; 12: 423-8.
21. Barbaras R, Puchois P, Fruchart JD, Ailhaud G. Cholesterol afflux from cultured adipose cells is mediated by LPA-I particles but not by LPA-I:A-II particles. Boichem Biophys Res Commun 1987; 142: 63-9.
22. Alaupovic P, Knight-Gibson C, Hodis HN, Mack WJ, Cashm-Hemphill L, Blankenhorn DH. Effect of apoB-containing lipoprotein particles on the progression of atherosclerotic lesions in the Monitored Atherosclerosis Regression Study (MARS). Atherosclerosis 1994; 109: 154.